Neil Brewis, PhD., DSc

2021

In 2021, Neil Brewis, PhD., DSc earned a total compensation of $838.4K as Chief Scientific Officer at F-star Therapeutics, a 50% decrease compared to previous year.

Compensation breakdown

Bonus$107,821
Option Awards$126,793
Salary$412,685
Stock Awards$154,260
Other$36,857
Total$838,416

DSc received $412.7K in salary, accounting for 49% of the total pay in 2021.

DSc also received $107.8K in bonus, $126.8K in option awards, $154.3K in stock awards and $36.9K in other compensation.

Rankings

In 2021, Neil Brewis, PhD., DSc's compensation ranked 9,341st out of 12,415 executives tracked by ExecPay. In other words, DSc earned more than 24.8% of executives.

ClassificationRankingPercentile
All
9,341
out of 12,415
25th
Division
Manufacturing
4,142
out of 5,505
25th
Major group
Chemicals And Allied Products
1,826
out of 2,375
23rd
Industry group
Drugs
1,620
out of 2,096
23rd
Industry
Pharmaceutical Preparations
1,203
out of 1,546
22nd
Source: SEC filing on April 22, 2022.

DSc's colleagues

We found three more compensation records of executives who worked with Neil Brewis, PhD., DSc at F-star Therapeutics in 2021.

2021

Eliot Forster

F-star Therapeutics

Chief Executive Officer

2021

Darlene Deptula-Hicks

F-star Therapeutics

Chief Financial Officer

2021

Louis Kayitalire

F-star Therapeutics

Chief Medical Officer

News

You may also like